about
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, an...
Read More
7.02
-0.09
(-1.27%)
575.1K
XNAS Volume
XNAS 08 Aug, 2025 5:30 PM (EDT)
Medium Financial Strength
Mid Valuation
Technically Neutral
Mid-range Performer
These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks.
View Similar
Embed DVM
Mimedx Group Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..